<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32605607</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients.</ArticleTitle><Pagination><StartPage>23</StartPage><MedlinePgn>23</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-020-00203-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">MicroRNAs (miRNAs) are endogenous non-coding RNAs that regulate gene expression at the post-transcriptional level and are key modulators in neurodegenerative diseases. Overexpressed miRNAs play an important role in ALS; however, the pathogenic mechanisms of deregulated miRNAs are still unclear.</AbstractText><AbstractText Label="METHODS">We aimed to assess the dysfunction of RNAs or miRNAs in fALS (SOD1 mutations). We compared the RNA-seq of subcellular fractions in NSC-34 WT (hSOD1) and MT (hSOD1 (G93A)) cells to find altered RNAs or miRNAs. We identified that Hif1&#x3b1; and Mef2c were upregulated, and Mctp1 and Rarb were downregulated in the cytoplasm of NSC-34 MT cells.</AbstractText><AbstractText Label="RESULTS">SOD1 mutations decreased the level of miR-18b-5p. Induced Hif1&#x3b1; which is the target for miR-18b increased Mef2c expression as a transcription factor. Mef2c upregulated miR-206 as a transcription factor. Inhibition of Mctp1 and Rarb which are targets of miR-206 induces intracellular Ca<sup>2+</sup> levels and reduces cell differentiation, respectively. We confirmed that miR-18b-5p pathway was also observed in G93A Tg, fALS (G86S) patient, and iPSC-derived motor neurons from fALS (G17S) patient.</AbstractText><AbstractText Label="CONCLUSIONS">Our data indicate that SOD1 mutation decreases miR-18b-5p, which sequentially regulates Hif1&#x3b1;, Mef2c, miR-206, Mctp1 and Rarb in fALS-linked SOD1 mutation. These results provide new insights into the downregulation of miR-18b-5p dependent pathogenic mechanisms of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ki Yoon</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital 28 yongon-Dong, Chongno-gu, Seoul, 110-744, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yu Ri</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital 28 yongon-Dong, Chongno-gu, Seoul, 110-744, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Kyung Won</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital 28 yongon-Dong, Chongno-gu, Seoul, 110-744, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Mijung</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital 28 yongon-Dong, Chongno-gu, Seoul, 110-744, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Somyung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital 28 yongon-Dong, Chongno-gu, Seoul, 110-744, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Im</LastName><ForeName>Wooseok</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital 28 yongon-Dong, Chongno-gu, Seoul, 110-744, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Je-Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital 28 yongon-Dong, Chongno-gu, Seoul, 110-744, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Division of Mass Spectrometry Research, Korea Basic Science Institute, Daejun, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Yoon Ho</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Seoul Metropolitan Government Boramae Medical Center, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Manho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital 28 yongon-Dong, Chongno-gu, Seoul, 110-744, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jong-Il</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Jung-Joon</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seoul National University Hospital 28 yongon-Dong, Chongno-gu, Seoul, 110-744, Republic of Korea. jjsaint@snu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C581632">MIRN18 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hif1&#x3b1;</Keyword><Keyword MajorTopicYN="N">Mctp1 and Rarb</Keyword><Keyword MajorTopicYN="N">Mef2c</Keyword><Keyword MajorTopicYN="N">miRNAs</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32605607</ArticleId><ArticleId IdType="pmc">PMC7328278</ArticleId><ArticleId IdType="doi">10.1186/s40035-020-00203-4</ArticleId><ArticleId IdType="pii">10.1186/s40035-020-00203-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lagier-Tourenne C, Cleveland DW. Rethinking ALS: the FUS about TDP-43. Cell. 2009;136:1001&#x2013;1004. doi: 10.1016/j.cell.2009.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.03.006</ArticleId><ArticleId IdType="pmc">PMC3110083</ArticleId><ArticleId IdType="pubmed">19303844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao FB, Almeida S, Lopez-Gonzalez R. Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J. 2017;36:2931&#x2013;2950. doi: 10.15252/embj.201797568.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797568</ArticleId><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, Hart MP, Erion R, King OD, Diaz Z, Nakaya T, et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:2899&#x2013;2911. doi: 10.1093/hmg/dds116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds116</ArticleId><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Inukai Y, Nonaka T, Arai T, Yoshida M, Hashizume Y, Beach TG, et al. Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 2008;582:2899&#x2013;2904. doi: 10.1016/j.febslet.2008.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.07.027</ArticleId><ArticleId IdType="pubmed">18656473</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol. 2015;11:266&#x2013;279. doi: 10.1038/nrneurol.2015.57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.57</ArticleId><ArticleId IdType="pubmed">25896087</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B, Brown RH., Jr Silencing strategies for therapy of SOD1-mediated ALS. Neurosci Lett. 2017;636:32&#x2013;39. doi: 10.1016/j.neulet.2016.07.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.07.059</ArticleId><ArticleId IdType="pubmed">27507699</ArticleId></ArticleIdList></Reference><Reference><Citation>Naro&#x17c;na B, Langwi&#x144;ski W, Szczepankiewicz A. Non-coding RNAs in pediatric airway diseases. Genes. 2017;8:348. doi: 10.3390/genes8120348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes8120348</ArticleId><ArticleId IdType="pmc">PMC5748666</ArticleId><ArticleId IdType="pubmed">29186897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosik KS. The neuronal microRNA system. Nat Rev Neurosci. 2006;7:911&#x2013;920. doi: 10.1038/nrn2037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2037</ArticleId><ArticleId IdType="pubmed">17115073</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicker S, Schratt G. MicroRNAs in ALS: small pieces to the puzzle. EMBO J. 2015;34:2601&#x2013;2603. doi: 10.15252/embj.201592805.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592805</ArticleId><ArticleId IdType="pmc">PMC4641527</ArticleId><ArticleId IdType="pubmed">26369718</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AP, Wada S, Vergani L, Hock MB, Lamon S, L&#xe9;ger B, et al. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis. 2013;49:107&#x2013;117. doi: 10.1016/j.nbd.2012.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.08.015</ArticleId><ArticleId IdType="pubmed">22975021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed; E, Pantano L, Ba&#xf1;ez-Coronel M, Llorens F, Mi&#xf1;ones-Moyano E, Porta S, et al. A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 2010;38:7219&#x2013;7235. doi: 10.1093/nar/gkq575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq575</ArticleId><ArticleId IdType="pmc">PMC2978354</ArticleId><ArticleId IdType="pubmed">20591823</ArticleId></ArticleIdList></Reference><Reference><Citation>Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci. 2008;28:14341&#x2013;14346. doi: 10.1523/JNEUROSCI.2390-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2390-08.2008</ArticleId><ArticleId IdType="pmc">PMC3124002</ArticleId><ArticleId IdType="pubmed">19118166</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;bert SS, Horr&#xe9; K, Nicola&#xef; L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A. 2008;105:6415&#x2013;6420. doi: 10.1073/pnas.0710263105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0710263105</ArticleId><ArticleId IdType="pmc">PMC2359789</ArticleId><ArticleId IdType="pubmed">18434550</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 2011;121:193&#x2013;205. doi: 10.1007/s00401-010-0756-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0756-0</ArticleId><ArticleId IdType="pmc">PMC3073518</ArticleId><ArticleId IdType="pubmed">20936480</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehrke S, Imai Y, Sokol N, Lu B. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature. 2010;466:637&#x2013;641. doi: 10.1038/nature09191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09191</ArticleId><ArticleId IdType="pmc">PMC3049892</ArticleId><ArticleId IdType="pubmed">20671708</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho HJ, Liu G, Jin SM, Parisiadou L, Xie C, Yu J, et al. MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet. 2013;22:608&#x2013;620. doi: 10.1093/hmg/dds470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds470</ArticleId><ArticleId IdType="pmc">PMC3542867</ArticleId><ArticleId IdType="pubmed">23125283</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012;122:3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, et al. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet. 2013;22:4127&#x2013;4135. doi: 10.1093/hmg/ddt261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt261</ArticleId><ArticleId IdType="pmc">PMC3781640</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Pedersen JS, Kwon SC, Belair CD, Kim YK, Yeom KH, et al. Posttranscriptional crossregulation between Drosha and DGCR8. Cell. 2009;136:75&#x2013;84. doi: 10.1016/j.cell.2008.10.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.10.053</ArticleId><ArticleId IdType="pmc">PMC2680683</ArticleId><ArticleId IdType="pubmed">19135890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415&#x2013;419. doi: 10.1038/nature01957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01957</ArticleId><ArticleId IdType="pubmed">14508493</ArticleId></ArticleIdList></Reference><Reference><Citation>Diederichs S, Haber DA. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell. 2007;131:1097&#x2013;1108. doi: 10.1016/j.cell.2007.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.032</ArticleId><ArticleId IdType="pubmed">18083100</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Li Y, Zhang H, Huang P, Luthra R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene. 2010;29:4362&#x2013;4368. doi: 10.1038/onc.2010.193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2010.193</ArticleId><ArticleId IdType="pubmed">20498629</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E, Cha MJ, Hwang KC. Roles of calcium regulating MicroRNAs in cardiac ischemia-reperfusion injury. Cells. 2014;3:899&#x2013;913. doi: 10.3390/cells3030899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells3030899</ArticleId><ArticleId IdType="pmc">PMC4197635</ArticleId><ArticleId IdType="pubmed">25216032</ArticleId></ArticleIdList></Reference><Reference><Citation>Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell. 2007;27:435&#x2013;448. doi: 10.1016/j.molcel.2007.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2007.07.015</ArticleId><ArticleId IdType="pmc">PMC3139456</ArticleId><ArticleId IdType="pubmed">17679093</ArticleId></ArticleIdList></Reference><Reference><Citation>Berridge MJ, Bootman MD, Lipp P. Calcium--a life and death signal. Nature. 1998;395:645&#x2013;648. doi: 10.1038/27094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/27094</ArticleId><ArticleId IdType="pubmed">9790183</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu L, Yu H, Liang F. Multiple C2 domains transmembrane protein 1 is expressed in CNS neurons and possibly regulates cellular vesicle retrieval and oxidative stress. J Neurochem. 2015. 10.1111/jnc.13251.</Citation><ArticleIdList><ArticleId IdType="pubmed">26195140</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin OH, Han W, Wang Y, S&#xfc;dhof TC. Evolutionarily conserved multiple C2 domain proteins with two transmembrane regions (MCTPs) and unusual Ca2+ binding properties. J Biol Chem. 2005;280:1641&#x2013;1651. doi: 10.1074/jbc.M407305200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M407305200</ArticleId><ArticleId IdType="pubmed">15528213</ArticleId></ArticleIdList></Reference><Reference><Citation>Tradewell ML, Cooper LA, Minotti S, Durham HD. Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention. Neurobiol Dis. 2011;42:265&#x2013;275. doi: 10.1016/j.nbd.2011.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.01.016</ArticleId><ArticleId IdType="pubmed">21296666</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Sch&#xfc;tz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835&#x2013;839. doi: 10.1016/0092-8674(95)90199-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90199-X</ArticleId><ArticleId IdType="pmc">PMC6159888</ArticleId><ArticleId IdType="pubmed">8521507</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Dawson MI, Agadir A, Lee MO, Jong L, Hobbs PD, et al. Regulation of RAR beta expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: effect on growth inhibition and apoptosis induction. Int J Cancer. 1998;75:88&#x2013;95. doi: 10.1002/(SICI)1097-0215(19980105)75:1&lt;88::AID-IJC14&gt;3.0.CO;2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0215(19980105)75:1&lt;88::AID-IJC14&gt;3.0.CO;2-9</ArticleId><ArticleId IdType="pubmed">9426695</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto C, C&#xe1;rdenas P, Osses N, Henr&#xed;quez JP. Characterization of Wnt/&#x3b2;-catenin and BMP/Smad signaling pathways in an in vitro model of amyotrophic lateral sclerosis. Front Cell Neurosci. 2013;7:1&#x2013;15. doi: 10.3389/fncel.2013.00239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00239</ArticleId><ArticleId IdType="pmc">PMC3847560</ArticleId><ArticleId IdType="pubmed">24348333</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y, Mirnics ZK, Yan C, Nylander KD, Schor NF. Bcl-2 mediates induction of neural differentiation. Oncogene. 2003;22:5515&#x2013;5518. doi: 10.1038/sj.onc.1206844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1206844</ArticleId><ArticleId IdType="pubmed">12934111</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruman II, Pedersen WA, Springer JE, Mattson MP. ALS-linked cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol. 1999;160:28&#x2013;39. doi: 10.1006/exnr.1999.7190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1999.7190</ArticleId><ArticleId IdType="pubmed">10630188</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinton P, Ferrari D, Rapizzi E, Di Virgilio F, Pozzan T, Rizzuto R. The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J. 2001;20:2690&#x2013;2701. doi: 10.1093/emboj/20.11.2690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.11.2690</ArticleId><ArticleId IdType="pmc">PMC125256</ArticleId><ArticleId IdType="pubmed">11387204</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Park HS, Hong S, Kang S. Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS. Exp Mol Med. 2016;48:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5192071</ArticleId><ArticleId IdType="pubmed">27932790</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Qian K, Du Z, Cao J, Petersen A, Liu H, et al. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell. 2014;14:796&#x2013;809. doi: 10.1016/j.stem.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.02.004</ArticleId><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255:1707&#x2013;1710. doi: 10.1126/science.1553558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1553558</ArticleId><ArticleId IdType="pubmed">1553558</ArticleId></ArticleIdList></Reference><Reference><Citation>Im W, Ban JJ, Chung JY, Lee ST, Chu K, Kim M. Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model. Sci Rep. 2015;5:1&#x2013;10. doi: 10.1038/srep16887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16887</ArticleId><ArticleId IdType="pmc">PMC4653614</ArticleId><ArticleId IdType="pubmed">26586297</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho MS, Hwang DY, Kim DW. Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale. Nat Protoc. 2008;3:1888&#x2013;1894. doi: 10.1038/nprot.2008.188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.188</ArticleId><ArticleId IdType="pubmed">19008875</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti S, Nizzardo M, Nardini M, Donadoni C, Salani S, Ronchi D, et al. Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice. Brain. 2010;133:465&#x2013;481. doi: 10.1093/brain/awp318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp318</ArticleId><ArticleId IdType="pubmed">20032086</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH., Jr Emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015;125:1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15:509&#x2013;524. doi: 10.1038/nrm3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3838</ArticleId><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KY, Hwang YJ, Jung MK, Choe J, Kim Y, Kim S, et al. A multifunctional protein EWS regulates the expression of Drosha and microRNAs. Cell Death Differ. 2014;21:136&#x2013;145. doi: 10.1038/cdd.2013.144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2013.144</ArticleId><ArticleId IdType="pmc">PMC3857629</ArticleId><ArticleId IdType="pubmed">24185621</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan J, Ahuja P, Bodenmann S, Knapik D, Perriard E, Krek W, et al. Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function. Circ Res. 2008;103:1139&#x2013;1146. doi: 10.1161/01.RES.0000338613.89841.c1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000338613.89841.c1</ArticleId><ArticleId IdType="pubmed">18849322</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A. 2006;103:8721&#x2013;8726. doi: 10.1073/pnas.0602831103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602831103</ArticleId><ArticleId IdType="pmc">PMC1482645</ArticleId><ArticleId IdType="pubmed">16731620</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolt KS, Mishra MK, Karar J, Baig MA, Ahmed Z, Pasha MA. cDNA cloning, gene organization and variant specific expression of HIF-1 alpha in high altitude yak (Bos grunniens) Gene. 2007;386:73&#x2013;80. doi: 10.1016/j.gene.2006.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2006.08.004</ArticleId><ArticleId IdType="pubmed">17045424</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006;7:710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KY, Lee HW, Shim YM, Mook-Jung I, Jeon GS, Sung JJ. A phosphomimetic mutant TDP-43 (S409/410E) induces Drosha instability and cytotoxicity in Neuro 2A cells. Biochem Biophys Res Commun. 2015;464:236&#x2013;243. doi: 10.1016/j.bbrc.2015.06.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.06.125</ArticleId><ArticleId IdType="pubmed">26102026</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateralsclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki M, Esumi E, Nakano I. Is motoneuronal cell death in amyotrophic lateral sclerosis apoptosis? Neuropathology. 2005;25:381&#x2013;387. doi: 10.1111/j.1440-1789.2005.00648.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2005.00648.x</ArticleId><ArticleId IdType="pubmed">16382789</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>